Huntington National Bank Purchases 268 Shares of Integer Holdings Co. (NYSE:ITGR)

Huntington National Bank boosted its position in shares of Integer Holdings Co. (NYSE:ITGR) by 8,933.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 271 shares of the medical equipment provider’s stock after acquiring an additional 268 shares during the quarter. Huntington National Bank’s holdings in Integer were worth $35,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Contravisory Investment Management Inc. grew its holdings in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the last quarter. Xponance Inc. grew its stake in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock worth $245,000 after acquiring an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV increased its position in shares of Integer by 0.9% during the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock worth $1,504,000 after acquiring an additional 107 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after purchasing an additional 142 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its stake in Integer by 3.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after purchasing an additional 205 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

ITGR has been the subject of several research reports. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Citigroup increased their target price on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Bank of America increased their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Finally, KeyCorp boosted their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Integer has a consensus rating of “Moderate Buy” and an average target price of $139.75.

Integer Trading Down 0.7 %

NYSE:ITGR opened at $133.53 on Wednesday. The firm has a 50 day moving average of $129.41 and a 200 day moving average of $122.93. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 52 week low of $84.75 and a 52 week high of $140.91. The stock has a market capitalization of $4.48 billion, a price-to-earnings ratio of 41.21, a PEG ratio of 1.91 and a beta of 1.09.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same quarter in the prior year, the business posted $1.27 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Integer Holdings Co. will post 5.34 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.